Grantham, Mayo, Van Otterloo & Co (GMO)’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
Other funds holding DVA
GCM
Grantham, Mayo, Van Otterloo & Co (GMO)'s DVA Position: Q3 2022 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of DaVita (DVA) in Q3 2022, closing a stake of 9,727 shares — an estimated $778K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DVA in Q2 2019 and held it in 8 quarters. The position peaked at $29.2M in Q2 2019. 443 funds tracked by Wall St. Rank hold DVA as of Q3 2022.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining DaVita position as of Q3 2022 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 9,727 DaVita shares in Q3 2022, an estimated $778K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in DaVita in Q2 2019 and held it in 8 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s DaVita position peaked at $29.2M in Q2 2019.
- 443 funds tracked by Wall St. Rank held DaVita as of Q3 2022.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2022, filed 10 Nov 2022.